Prevalence of hyperhomocysteinemia in the study population and odds ratio for cerebral vein thrombosis
Hyperhomocysteinemia* . | Patients n (%) . | Controls n (%) . | Odds ratio (95% CI) . |
|---|---|---|---|
| Total | 33 (27.3) | 20 (8.3) | 4.2 (2.3-7.6) |
| Men | 10 (33.3) | 4 (6.6) | 7.0 (2.0-24.9) |
| Women | 23 (25.3) | 16 (8.8) | 3.5 (1.7-7.1) |
| High fasting tHcy levels | |||
| Total | 14 (11.6) | 12 (5.0) | 2.5 (1.1-5.6) |
| Men | 5 (16.6) | 3 (5.0) | 3.8 (0.8-17.2) |
| Women | 9 (9.9) | 9 (4.9) | 2.1 (0.8-5.6) |
| High PML increments | |||
| Total | 26 (21.5) | 12 (5.0) | 5.2 (2.5-10.8) |
| Men | 6 (20.0) | 3 (5.0) | 4.8 (1.1-26.0) |
| Women | 20 (22.0) | 9 (4.9) | 5.4 (2.4-12.5) |
Hyperhomocysteinemia* . | Patients n (%) . | Controls n (%) . | Odds ratio (95% CI) . |
|---|---|---|---|
| Total | 33 (27.3) | 20 (8.3) | 4.2 (2.3-7.6) |
| Men | 10 (33.3) | 4 (6.6) | 7.0 (2.0-24.9) |
| Women | 23 (25.3) | 16 (8.8) | 3.5 (1.7-7.1) |
| High fasting tHcy levels | |||
| Total | 14 (11.6) | 12 (5.0) | 2.5 (1.1-5.6) |
| Men | 5 (16.6) | 3 (5.0) | 3.8 (0.8-17.2) |
| Women | 9 (9.9) | 9 (4.9) | 2.1 (0.8-5.6) |
| High PML increments | |||
| Total | 26 (21.5) | 12 (5.0) | 5.2 (2.5-10.8) |
| Men | 6 (20.0) | 3 (5.0) | 4.8 (1.1-26.0) |
| Women | 20 (22.0) | 9 (4.9) | 5.4 (2.4-12.5) |
Hyperhomocysteinemia is high fasting tHcy level or high PML increment, or both.